The Mental Health Australia General Clinical Trials Network
Login
MAGNET  > Platforms  > Assessment  > Assessment Search  > Massachusetts General Hospital Antidepressant Treatment Response Questionnaire

Massachusetts General Hospital Antidepressant Treatment Response Questionnaire (MGH ATRQ)

Description

The MGH ATRQ is a self-report scale of treatment resistance in depression. The MGH ATRQ collects information on any antidepressant medications which someone is taking and if they believe the drug has contributed to an improvement in symptoms.The MGH ATRQ is a self-report scale of treatment resistance in depression. The MGH ATRQ collects information on any antidepressant medications which someone is taking and if they believe the drug has contributed to an improvement in symptoms.

Test Features

Administration details

Administration type: Self-report Timeframe:

Current

 Approx time: 05-15 minutes

Accessing the assessment and manual information

Access information:

License details

Free to Use?

Yes, free to use for academic purposes. However, a licence from Massachusetts General Hospital is required.

 License details:
  • Please contact Sherene Shenouda (SMSHENOUDA@PARTNERS.ORG) or Taylor Walicki (TWALICKI@PARTNERS.ORG) to request a licence.

Reliability and Validity

Note: Listed publications are for the English version of the assessment only
  • Chandler, G. M., Iosifescu, D. V., Pollack, M. H., Targum, S. D., & Fava, M. (2010). Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neuroscience & Therapeutics, 16(5), 322-325. https://doi.org/10.1111%2Fj.1755-5949.2009.00102.x

Further information:

The MGH ATRQ was originally developed in 1996 (see: Fava, M., & Davidson, K. G. (1996). Definition and epidemiology of treatment-resistant depression. Psychiatric Clinics of North America, 19(2), 179-200. https://doi.org/10.1016/S0193-953X(05)70283-5), however, the scale was updated and improved by Fava in 2003 (Fava, M. (2003). Diagnosis and definition of treatment-resistant depression. Biological Psychiatry, 53(8), 649-659. https://doi.org/10.1016/S0006-3223(03)00231-2).